Results
|
81.
|
|
|
82.
|
|
|
83.
|
|
|
84.
|
|
|
85.
|
|
|
86.
|
|
|
87.
|
|
|
88.
|
|
|
89.
|
|
|
90.
|
|
|
91.
|
|
|
92.
|
|
|
93.
|
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. [electronic resource] by
- Logigian, E L
- Martens, W B
- Moxley, R T
- McDermott, M P
- Dilek, N
- Wiegner, A W
- Pearson, A T
- Barbieri, C A
- Annis, C L
- Thornton, C A
- Moxley, R T
Producer: 20100525
In:
Neurology vol. 74
Availability: No items available.
|
|
94.
|
Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. [electronic resource] by
- Shadick, N A
- Phillips, C B
- Sangha, O
- Logigian, E L
- Kaplan, R F
- Wright, E A
- Fossel, A H
- Fossel, K
- Berardi, V
- Lew, R A
- Liang, M H
Producer: 19991214
In:
Annals of internal medicine vol. 131
Availability: No items available.
|
|
95.
|
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. [electronic resource] by
- Shadick, N A
- Phillips, C B
- Logigian, E L
- Steere, A C
- Kaplan, R F
- Berardi, V P
- Duray, P H
- Larson, M G
- Wright, E A
- Ginsburg, K S
- Katz, J N
- Liang, M H
Producer: 19941011
In:
Annals of internal medicine vol. 121
Availability: No items available.
|